Arkolith/Insider Trading/INFI/Form 4

Peluso Stephane

Chief Scientific OfficerINFINITY PHARMACEUTICALS, INC. (INFI) · full profile →Form 4 · filed Aug 4, 2022
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2022Buy(S)15K$0.66$10K37K
Aug 2, 2022Option exercise(M)50K——52K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 2, 2022Option exercise(M)50K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-028234) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML